Use access key #2 to skip to page content.
$47.56 -1.02 (-2.10%)
8/20/2008 3:16 PM

AstraZeneca plc (ADR) (AZN)

CAPS Rating:
****

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

View All Commentary (AZN)

Recs

0

Avatar ivstaline (< 20) Submitted: 7/09/08 10:40 AM : Outperform Start Price: $47.78 AZN Score: -0.52

CRESTOR

Report this Post Replies: 0 | Reply

Featured Broker Partners